Negative regulation of glycoprotein metabolic process

pathway activity — cross-omics
GO:1903019Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of glycoprotein metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the LUNG_NSCLC_LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are GAREM2, POLR1E, and EIF3L, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of glycoprotein metabolic process activity versus GAREM2 in LUNG_NSCLC_LUAD (Pearson r = -0.37).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUNG_NSCLC_LUADGAREM2 →-0.858-0.903.001<.00136
STOMACHPOLR1E →-1.433-1.465.001<.00135
LARGE_INTESTINEEIF3L →-0.528-0.864.003<.00134
LARGE_INTESTINEENO2 →-1.745-1.008<.001<.00134
LUNG_SCLCTM9SF2 →+0.821+1.030.003<.00134
BLOOD_LymphomaATP10D →-1.002-0.890.001.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1903019 vs GAREM2 — LUNG_NSCLC_LUAD

Per-sample scatter of Negative regulation of glycoprotein metabolic process activity vs GAREM2 in LUNG_NSCLC_LUAD.

Explore this scatter interactively →

Exploration